Company Information
CIN
Status
Date of Incorporation
01 March 1966
State / ROC
Ernakulam / ROC Ernakulam
Last Balance Sheet
31 March 2023
Last Annual Meeting
03 December 2022
Paid Up Capital
155,400,000
Authorised Capital
3,000,000,000
Directors
Anitha Thampi
Director/Designated Partner
over 2 years ago
over 2 years ago
Beji Kavumkal George
Director/Designated Partner
over 2 years ago
over 2 years ago
Elamthurthi Achuthan Subramanian
Director/Designated Partner
over 2 years ago
over 2 years ago
Jaideep Kumar Mishra
Director/Designated Partner
about 3 years ago
about 3 years ago
Roli Singh
Director/Designated Partner
almost 4 years ago
almost 4 years ago
Adarsh Pal Vig
Director/Designated Partner
almost 4 years ago
almost 4 years ago
Neeta Boochra
Director/Designated Partner
almost 4 years ago
almost 4 years ago
Geeta Sharma
Director/Designated Partner
over 7 years ago
over 7 years ago
Nikunja Bihari Dhal
Nominee Director
over 11 years ago
over 11 years ago
Ayyappan Madhavan Nair
Managing Director
over 17 years ago
over 17 years ago
Past Directors
Sanjay Kumar
Nominee Director
almost 4 years ago
almost 4 years ago
Vijaychander Reddy Pesaru
Director
almost 6 years ago
almost 6 years ago
Dharmendra Singh Gangwar
Nominee Director
over 6 years ago
over 6 years ago
Mandeep K Bhandari
Nominee Director
over 6 years ago
over 6 years ago
Rakesh Kumar Vats
Nominee Director
almost 7 years ago
almost 7 years ago
Arun Singhal
Managing Director
about 7 years ago
about 7 years ago
Rajasekar Timothy
Whole Time Director
over 8 years ago
over 8 years ago
Aradhana Johri
Director
almost 9 years ago
almost 9 years ago
Lav Agarwal
Nominee Director
almost 9 years ago
almost 9 years ago
Rakesh Prasad Khandelwal
Managing Director
over 9 years ago
over 9 years ago
Vijaya Srivastava
Nominee Director
almost 11 years ago
almost 11 years ago
Dharitri Panda
Nominee Director
almost 11 years ago
almost 11 years ago
Babu Thomas .
Whole Time Director
about 11 years ago
about 11 years ago
Sanjay Kumar Srivastava
Nominee Director
almost 13 years ago
almost 13 years ago
Santhana Krishnan
Whole Time Director
almost 13 years ago
almost 13 years ago
Mohandas Karunakaran Nair
Director
almost 13 years ago
almost 13 years ago
Simhambhatla Kameswara Rao
Nominee Director
about 13 years ago
about 13 years ago
Sreekumar Prabhakaran Nair
Company Secretary
over 13 years ago
over 13 years ago
Arun Kumar Panda
Nominee Director
almost 15 years ago
almost 15 years ago
Aarti Vij
Director
about 15 years ago
about 15 years ago
Sanjiv Kapoor
Director
about 15 years ago
about 15 years ago
Braj Kishore Prasad
Nominee Director
almost 16 years ago
almost 16 years ago
Suresh Kumar Krishna Panicker Kalampu Kattu
Whole Time Director
almost 17 years ago
almost 17 years ago
Shakuntala Doley Gamlin
Nominee Director
over 17 years ago
over 17 years ago
Naved Masood
Nominee Director
over 17 years ago
over 17 years ago
Bhaskaran Nair Chandrasekharan Nair
Whole Time Director
about 18 years ago
about 18 years ago
Manglavil Daivanayakom Sreekumar
Whole Time Director
about 18 years ago
about 18 years ago
Venugopal Sanjeevi .
Director
over 18 years ago
over 18 years ago
Vezhaparambil Ammunninair Sasidharan Nair
Company Secretary
over 28 years ago
over 28 years ago
Patents
The present invention relates to an automatic three line sealing machine for condom. The machine comprises a three line vibratory bowl feeder, a three line oil dosing mechanism, a three line squeeze mechanism, a three line foil feeding mechanism, a three line online stamping unit and a three line rectangular sealing...
The present invention discloses a method to determine the precise concentration of Follicle Stimulating hormone (FSH), present in human serum. It involves developing a graphene (oxide) based chemiluminescence (and/or) Enzyme Linked Immuno Sorbent Assay (ELISA) diagnostic technology and a kit to determine the concent...
The present invention discloses a method to determine the precise concentration of Luteinizing hormone (LH), present in human serum. It involves developing a graphene (oxide)based chemiluminescence (and/or) Enzyme Linked Immuno Sorbent Assay (ELISA) diagnostic technology and a kit to determine the concentration of t...
The present invention discloses a method to determine the precise concentration of Anti Mullerian hormone (AMH), present in human serum. It involves developing a graphene (oxide) based chemiluminescence (and/or) Enzyme Linked Immuno Sorbent Assay (ELISA) diagnostic technology and a kit to determine the concentration...
The present invention discloses an automatic condom dipping machine for production of male condoms without manual intervention until the vulcanizing stage by incorporating online powder finishing & vulcanizing operations. The apparatus consists of a molding unit and a powder finishing unit. The molding unit includes...
ABSTRACT
The present invention provides a pharmaceutical composition and oral dosage forms with an instant orange juice powder in a sachet to increase bioavailability of drugs. The pharmaceutical composition comprises iron and calcium particles coated with a mucoadhesive polymer. The polymer improves the absorption...
A novel herbal contraceptive formulation for the delivery of spermicidal and anti-trichomonas agent, Sapindoside B to the vaginal cavity is provided. Different pharmaceutical formulations namely muco-adhesive film, foaming pessary, soft gelatine capsule pessary, compressed pessary, gel, cream and saponin incorporate...
ABSTRACT:
The present invention relates to a sublingual oxytocin film or tablet formulation and a method for ameliorating sexual dysfunction, male factor infertility and postpartum haemorrhage. The composition includes an active ingredient oxytocin, one or more saliva simulating agent, one or more polyol to prevent...
The present invention relates to an antifungal herbal formulation for treatment of vaginal
candidiasis comprising three medicinal plant extracts namely Curcuma longa, Ventilago
madaraspetana and Terminalia chebula. The herbal formulation of the present invention is
effective against three different species of Can...
A novel intrauterine contraceptive device of the present invention is developed to surmount the problem prevailing with the conventional contraceptive device. The IUD of the present invention is covered with a thin layer of a biodegradable/bioabsorbable polymer, to control the excessive release of copper ion in the ...
The present invention relates to antimicrobial biocompatible, absorbable-coated surgical sutures containing nanosilver particles which inhibit growth of bacteria and fungi and prevent the infection due to microbes.
The method of preparing the suture comprises Preparing a solution of nano silver particles by dissolv...
A novel spacer balloon device has two parts or sacs called B-part and R-part which surround the Fletcher-Suit applicator used in brachytherapy in the treatment of cancer of the uterine cervix. The balloons inflated with liquid or air independently can be used in pushing aside critical organs like bladder and rectum ...
The invention provides a new and an improved female condom product and a method for manufacturing the same. The female condom product assembly includes a tubular sheath, an exterior bead and a retention device. The tubular sheath is manufactured by dipping process and an exterior bead is formed by rolling the tubula...
The present invention relates to poly(glycerol sebacate) based condoms produced from glycerol, glycerol derivatives, sebacic acid, nanomaterials such as graphene oxide/reduced graphene oxide/clay/silica, 3-diamino-2-hydroxy propane/ bis hydroxy ethylene terephthalate/poly tetra methylene glycol/furan dicarboxylic ac...
The present invention relates to a simple process for the preparation of Ormeloxifene (I), a
non-hormonal oral contraceptive and its derivatives. The process as shown in FIG. 2
comprises the steps of: Perkin reaction between 4-hydroxybenzaldehyde (II) and
phenylacetic acid (III) to give 3-(4-acetoxyphenyl)-2-phen...
The present invention relates to an aqueous gel formulation and its method of preparation
using combination of four or five medicinal plants for preventing sexually transmitted HIV-1.
The gel formulation comprises 50% aqueous ethanolic extracts of medicinal plants namely
Terminalia chebula, Phyllanthus emblica, L...
Registered Trademarks
[Class : 5] Contraceptive Preparations; Chemical Contraceptives; Medicinal, Pharmaceutical And Veterinary Preparations; Biological And Chemical Preparations; Sanitary Preparation For Medical Purposes; Dietetic Substances Adapted For Medical Use; Food For Babies; Plasters, Materials For Dressing; Material For Stopping Teeth And Dental Wax; Disinfectants; Preparation For Dest...
[Class : 10] Menstrual Cups; Menstrual Cups (Intravaginal Utensils For Menstruation).
[Class : 21] Soap Dispensers; Automatic Soap Dispensers; Dispensers For Liquid Soap For Household Purposes; Napkin Dispensers For Household Purposes, Use; Dispensers For Cleaning And Disinfecting Solutions; Manually Actuated Pump Dispensers For Attachment To Containers For Use In Dispensing Liquids; Body Cleanser Dispensers; Dispensers For Cleaning Preparations; Pump Dispens...
View +163 more Brands for Hll Lifecare Limited.
Charges
30 June 2017
Hdfc Bank Limited
21 Crore
15 March 2014
Hdfc Bank Limited
75 Crore
03 February 2014
Canara Bank
250 Crore
16 December 2013
Hdfc Bank Limited
92 Crore
10 February 2007
State Bank Of India
10 Crore
30 March 1994
State Bank Of India
617 Crore
16 January 2014
Indusind Bank Ltd.
65 Crore
27 March 2014
Indusind Bank Ltd.
42 Crore
27 February 2013
State Bank Of India
32 Crore
24 March 2014
Axis Bank Limited
305 Crore
24 June 2020
State Bank Of India
70 Crore
30 June 2017
Hdfc Bank Limited
0
15 March 2014
Hdfc Bank Limited
0
24 June 2020
State Bank Of India
0
30 March 1994
State Bank Of India
0
16 December 2013
Hdfc Bank Limited
0
27 February 2013
State Bank Of India
0
27 March 2014
Indusind Bank Ltd.
0
24 March 2014
Axis Bank Limited
0
03 February 2014
Canara Bank
0
10 February 2007
State Bank Of India
0
16 January 2014
Indusind Bank Ltd.
0
30 June 2017
Hdfc Bank Limited
0
15 March 2014
Hdfc Bank Limited
0
24 June 2020
State Bank Of India
0
30 March 1994
State Bank Of India
0
16 December 2013
Hdfc Bank Limited
0
27 February 2013
State Bank Of India
0
27 March 2014
Indusind Bank Ltd.
0
24 March 2014
Axis Bank Limited
0
03 February 2014
Canara Bank
0
10 February 2007
State Bank Of India
0
16 January 2014
Indusind Bank Ltd.
0
30 June 2017
Hdfc Bank Limited
0
15 March 2014
Hdfc Bank Limited
0
24 June 2020
State Bank Of India
0
30 March 1994
State Bank Of India
0
16 December 2013
Hdfc Bank Limited
0
27 February 2013
State Bank Of India
0
27 March 2014
Indusind Bank Ltd.
0
24 March 2014
Axis Bank Limited
0
03 February 2014
Canara Bank
0
10 February 2007
State Bank Of India
0
16 January 2014
Indusind Bank Ltd.
0
Documents
Form MSME FORM I-25042024_signed
Form Addendum to AOC-4 CSR-18042024_signed
Form Addendum to AOC-4 CSR-28032024_signed
Approval letter for extension of AGM;-29012024
List of share holders, debenture holders;-29012024
Copy of MGT-8-29012024
Form MGT-7-29012024_signed
XBRL document in respect Consolidated financial statement-11012024
Approval letter of extension of financial year of AGM-11012024
Supplementary or test audit report under section 143-11012024
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-11012024
Form AOC-4(XBRL)-11012024_signed
Form MSME FORM I-16122023_signed
Form MSME FORM I-08122023_signed
Form MSME FORM I-05112023_signed
Form MSME FORM I-04112023_signed
Form MSME FORM I-30102023
Form AOC-4(XBRL)-01092023_signed
Form MSME FORM I-29082023_signed
Form MSME FORM I-28042023_signed
Details of comments of CAG if India-20032023
Supplementary or test audit report under section 143-20032023
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-20032023
XBRL document in respect Consolidated financial statement-20032023
Approval letter of extension of financial year of AGM-20032023
Form AOC-4(XBRL)-20032023_signed
List of share holders, debenture holders;-02022023
Approval letter for extension of AGM;-02022023
Copy of MGT-8-02022023
Form MGT-7-02022023_signed
